表紙
市場調查報告書
商品編碼
1044748

基因編輯的變異檢測套件的全球市場:各技術(CRISPR/Cas9,TALENs/MegaTALs,ZFN,兆核酸水解酵素),各終端用戶,各地區的市場規模,佔有率及趨勢分析,各市場區隔預測(2021年∼2028年)

Mutation Detection Kits In Genome Editing Market Size, Share & Trends Analysis Report By Technology (CRISPR/Cas9, TALENs/MegaTALs, ZFN, Meganucleases), By End-use, By Region, And Segment Forecasts, 2021 - 2028

出版日期: | 出版商: Grand View Research, Inc. | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球基因編輯的變異檢測套件的市場規模,預計從2021年到2028年以17.3%的年複合成長率擴大,至2028年達到4億5,510萬美元。

遺傳基因改變技術的技術性進步,個體化醫療的採用擴大,合成遺傳基因和基因改造農作物的需求增加等大幅牽引市場。

本報告提供全球基因編輯的變異檢測套件市場相關調查分析,市場及產業展望,各市場區隔、各地區市場的展望,再加上競爭情形相關的系統性資訊。

目錄

第1章 調查手法和範圍

  • 資訊或資料分析
  • 資料分析模式
  • 市場形成與檢驗
  • 市場模式
  • 模式詳細內容
  • 最終用途的收益分配評估
  • COVID-19影響分析
  • 目的

第2章 摘要整理

第3章 市場變數,趨勢,及範圍

  • 市場趨勢與展望
  • 市場動態
  • 商務環境分析
  • 敲門界內或基因剔除手法趨勢分析
  • 技術的滲透與成長的展望的製圖,2020年(千美元)

第4章 基因編輯的變異檢測套件市場:各用途技術的跨區隔事業分析

  • CRISPR/Cas9
  • ZFN
  • TALEN/MegaTAL
  • Meganucleases
  • 其他

第5章 基因編輯市的變異檢測套件市場:各最終用途事業分析

  • 變異檢測套件(基因編輯)市場:各最終用途市場趨勢分析
  • 生物科技企業及製藥公司
  • 學術及政府研究機關
  • 委託研究機關

第6章 基因編輯的變異檢測套件市場:各地區市場的事業分析

  • 變異檢測套件(基因編輯)市場:各地區市場趨勢分析
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第7章 競爭分析

  • 主要企業的市場佔有率分析,2020年(%)
  • 策略性架構
    • 收購
    • 合資企業
    • 夥伴關係、合作
  • 市場參加的分類
  • 企業簡介
    • THERMOFISHER SCIENTIFICINC。
    • TAKARA BIO INC.
    • NEW ENGLAND BIOLABS
    • GENSCRIPT
    • INTEGRATED DNA TECHNOLOGIES INC.
    • PROMEGA CORPORATION
    • APPLIED BIOLOGICAL MATERIALS INC.
    • BIO-RAD LABORATORIES INC.
    • BIOVISION INC.
    • SYNTHEGO
    • ADDGENE
    • LUCIGEN
目錄
Product Code: GVR-4-68039-724-2

Mutation Detection Kit In Genome Editing Market Growth & Trends:

The global mutation detection kits in genome editing market size is expected to reach USD 455.1 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 17.3% from 2021 to 2028. Technological advancements in gene modification technologies, growing adoption of personalized medicine, and increasing demand for synthetic genes and GMOs have majorly driven the market.

The advent of CRISPR/Cas9 nuclease, TALEN, and ZFN allows easy and precise genome modification with no limitation by organisms. In recent times, this space has witnessed a slew of news emerging surrounding the advancement and application of gene editing tools for genetic disease treatment. For instance, in February 2021, researchers from the University of Illinois Chicago developed a new gene-editing tool that the programming of sequential cuts or edits over time.

COVID-19 has become a catalyst for the mutation detection kits market growth. Owing to the pandemic, the leading scientific community and market competitors are now focusing on deciphering the potential of gene editing techniques to prevent COVID-19 infection. CRISPR technology has been studied as a viable tool to alleviate the adverse impact of the pandemic and virus mutation. CRISPR can be utilized in various ways that can contribute to improving human health.

The TALENs/MegaTALs technology segment is expected to witness gradual growth from 2021 to 2028. The development of TALENs has led to major advancements in new therapy development. This technique is found to have more advanced potential gene therapy applications. The scientific community as well as operating players in the gene therapy market are showing a continued interest in the implementation of meganucleases in therapy development. Key players in the market are undertaking various strategic initiatives such as mergers & acquisitions and new product development to maintain their market presence.

Mutation Detection Kit In Genome Editing Market Report Highlights:

  • The CRISPR/Cas9 technology segment accounted for the largest revenue in 2020 and is expected to continue the trend in the forecast period. This can be attributed to the various advantages offered by this technique, along with expanding applications of the CRISPR/Cas9 technique
  • By end-use, academic and research institutes held the largest revenue share in 2020. This is attributed to the increasing R&D activities by these end-users in the genomics space
  • The CROs end-use segment is expected to witness significant growth throughout the forecast period. There exists a considerable demand for contract service providers for gene editing. An increasing number of startups and emerging companies engaged in the gene-editing process has fueled the demand for CROs in this market
  • North America has emerged as the highest revenue-generating region in 2020 owing to the presence of key players and developed healthcare infrastructure
  • Asia Pacific is anticipated to register the fastest CAGR throughout the forecast period. India and South Korea are majorly contributing to the regional market growth

Table of Contents

Chapter 1. Methodology And Scope

  • 1.1 Research Assumptions
  • 1.2 Research Methodology
    • 1.2.1 Estimates And Forecast Timeline
  • 1.3 Research Methodology
  • 1.4 Information Procurement
      • 1.4.1Purchased Database
    • 1.4.2 GVR'S Internal Database
    • 1.4.3 Secondary Sources
    • 1.4.4 Primary Research
      • 1.4.4.1 Manufacturers & Suppliers
      • 1.4.4.2 Secondary Data Sources
  • 1.5 Information or Data Analysis
    • 1.5.1 Data Analysis Models
  • 1.6 Market Formulation & Validation
  • 1.7 Market Model
    • 1.7.1 Model Details
      • 1.7.1.1 Parent Market Study
    • 1.7.2 Revenue Share Assessment Of End Use
  • 1.8 COVID-19 Impact Analysis
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2

Chapter 2. Executive Summary

  • 2.1 Market Summary, 2020
  • 2.2 Market Segmentation

Chapter 3. Market Variables, Trends, And Scope

  • 3.1 Market Trends and Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Technological advancements in gene editing technologies
      • 3.2.1.2 Increasing demand for synthetic genes and genetically modified organisms
      • 3.2.1.3 Growing adoption of personalized medicine
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Regulatory, and ethical challenges pertaining to the use of genetically modified products
    • 3.2.3 Market Opportunity Analysis
      • 3.2.3.1 Expanding applications of genome editing technologies in cell and gene therapy arena
  • 3.3 Business Environment Analysis
    • 3.3.1 SWOT Analysis; By Factor (Political & Legal, Economic, And Technological)
    • 3.3.2 Porter's Five Forces Analysis
  • 3.4 Trend Analysis on Knock In' Or 'Knock Out' Techniques
  • 3.5 Penetration and Growth Prospect Mapping for Technology, 2020 (USD Thousand)

Chapter 4. Mutation Detection Kits In Genome Editing Market: Technology By Application Cross Segment Business Analysis

  • 4.1 CRISPR/Cas9
    • 4.1.1 Genetically Modified Organisms (GMO) Analysis
    • 4.1.2 Disease Genotyping
    • 4.1.3 Typing Of Transgenic Plants
    • 4.1.4 Therapy Development
    • 4.1.5 Epigenetic Editing
  • 4.2 ZFN
    • 4.2.1 Genetically Modified Organisms (GMO) Analysis
    • 4.2.2 Disease Genotyping
    • 4.2.3 Typing Of Transgenic Plants
    • 4.2.4 Therapy Development
    • 4.2.5 Epigenetic Editing
  • 4.3 TALENs/MegaTALs
    • 4.3.1 Genetically Modified Organisms (GMO) Analysis
    • 4.3.2 Disease Genotyping
    • 4.3.3 Typing Of Transgenic Plants
    • 4.3.4 Therapy Development
    • 4.3.5 Epigenetic Editing
  • 4.4 Meganucleases
    • 4.4.1 Genetically Modified Organisms (GMO) Analysis
    • 4.4.2 Disease Genotyping
    • 4.4.3 Typing Of Transgenic Plants
    • 4.4.4 Therapy Development
    • 4.4.5 Epigenetic Editing
  • 4.5 Others

Chapter 5. Mutation Detection Kits In Genome Editing Market: End-Use Business Analysis

  • 5.1 Mutation Detection Kits (Genome Editing) Market: End-use Movement Analysis
  • 5.2 Biotechnology and Pharmaceutical Companies
    • 5.2.1 Mutation Detection Kits (Genome Editing) Market For Biotechnology And Pharmaceutical Companies, 2017 - 2028 (USD Thousand)
  • 5.3 Academic And Government Research Institutes
    • 5.3.1 Mutation Detection Kits (Genome Editing) Market For Academic And Government Research Institutes, 2017 - 2028 (USD Thousand)
  • 5.4 Contract Research Organizations
    • 5.4.1 Mutation Detection Kits (Genome Editing) Market For Contract Research Organizations, 2017 - 2028 (USD Thousand)

Chapter 6. Mutation Detection Kits In Genome Editing Market: Regional Business Analysis

  • 6.1 Mutation Detection Kits (Genome Editing) Market: Regional Movement Analysis
  • 6.2 North America
    • 6.2.1 North America Mutation Detection Kits (Genome Editing) Market, 2017 - 2028 (USD Thousand)
    • 6.2.2 U.S.
      • 6.2.2.1 U.S. mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
      • 6.2.2.2 U.S. (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.2.2.3 U.S. TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.2.2.4 U.S. ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.2.2.5 U.S. Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.2.2.6 U.S. mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
    • 6.2.3 Canada
      • 6.2.3.1 Canada mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
      • 6.2.3.2 Canada (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.2.3.3 Canada TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.2.3.4 Canada ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.2.3.5 Canada Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.2.3.6 Canada mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
  • 6.3 Europe
    • 6.3.1 Europe Mutation Detection Kits (Genome Editing) Market, 2017- 2028 (USD Thousand)
    • 6.3.2 Germany
      • 6.3.2.1 Germany mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
      • 6.3.2.2 Germany (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.3.2.3 Germany TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.3.2.4 Germany ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.3.2.5 Germany Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.3.2.6 Germany mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
    • 6.3.3 U.K.
      • 6.3.3.1 U.K. mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
      • 6.3.3.2 U.K. (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.3.3.3 U.K. TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.3.3.4 U.K. ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.3.3.5 U.K. Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.3.3.6 U.K. mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
    • 6.3.4 France
      • 6.3.4.1 France mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
      • 6.3.4.2 France (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.3.4.3 France TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.3.4.4 France ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.3.4.5 France Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.3.4.6 France mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
    • 6.3.5 Italy
      • 6.3.5.1 Italy mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
      • 6.3.5.2 Italy (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.3.5.3 Italy TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.3.5.4 Italy ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.3.5.5 Italy Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.3.5.6 Italy mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
    • 6.3.6 Spain
      • 6.3.6.1 Spain mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
      • 6.3.6.2 Spain (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.3.6.3 Spain TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.3.6.4 Spain ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.3.6.5 Spain Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.3.6.6 Spain mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific Mutation Detection Kits (Genome Editing) Market, 2017 - 2028 (USD Thousand)
    • 6.4.2 Japan
      • 6.4.2.1 Japan mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
      • 6.4.2.2 Japan (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.4.2.3 Japan TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.4.2.4 Japan ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.4.2.5 Japan Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.4.2.6 Japan mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
    • 6.4.3 China
      • 6.4.3.1 China mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
      • 6.4.3.2 China (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.4.3.3 China TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.4.3.4 China ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.4.3.5 China Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.4.3.6 China mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
    • 6.4.4 India
      • 6.4.4.1 India mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
      • 6.4.4.2 India (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.4.4.3 India TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.4.4.4 India ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.4.4.5 India Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.4.4.6 India mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
    • 6.4.5 South Korea
      • 6.4.5.1 South Korea mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
      • 6.4.5.2 South Korea (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.4.5.3 South Korea TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.4.5.4 South Korea ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.4.5.5 South Korea Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.4.5.6 South Korea mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
  • 6.5 Latin America
    • 6.5.1 Latin America Mutation Detection Kits (Genome Editing) Market, 2017 - 2028 (USD Thousand)
    • 6.5.2 Brazil
      • 6.5.2.1 Brazil mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
      • 6.5.2.2 Brazil (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.5.2.3 Brazil TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.5.2.4 Brazil ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.5.2.5 Brazil Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.5.2.6 Brazil mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
    • 6.5.3 Mexico
      • 6.5.3.1 Mexico mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
      • 6.5.3.2 Mexico (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.5.3.3 Mexico TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.5.3.4 Mexico ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.5.3.5 Mexico Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.5.3.6 Mexico mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
  • 6.6 MEA
    • 6.6.1 MEA Mutation Detection Kits (Genome Editing) Market, 2017 - 2028 (USD Thousand)
    • 6.6.2 SOUTH AFRICA
      • 6.6.2.1 South Africa mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
      • 6.6.2.2 South Africa (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.6.2.3 South Africa TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.6.2.4 South Africa ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.6.2.5 South Africa Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.6.2.6 South Africa mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
    • 6.6.3 Saudi Arabia
      • 6.6.3.1 Saudi Arabia mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
      • 6.6.3.2 Saudi Arabia (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.6.3.3 Saudi Arabia TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.6.3.4 Saudi Arabia ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.6.3.5 Saudi Arabia Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
      • 6.6.3.6 Saudi Arabia mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)

Chapter 7. Competitive Analysis

  • 7.1 Key Company Market Share Analysis, 2020 (%)
  • 7.2 Strategy Framework
    • 7.2.1 Acquisition
    • 7.2.2 Joint Venture
    • 7.2.3 Partnership And Collaboration
  • 7.3 Market Participation Categorization
  • 7.4 Company Profiles
    • 7.4.1 THERMOFISHER SCIENTIFIC INC.
      • 7.4.1.1 Company overview
      • 7.4.1.2 Financial performance
      • 7.4.1.3 Product benchmarking
      • 7.4.1.4 Strategic initiatives
    • 7.4.2 TAKARA BIO INC.
      • 7.4.2.1 Company overview
      • 7.4.2.2 Financial performance
      • 7.4.2.3 Product benchmarking
      • 7.4.2.4 Strategic initiatives
    • 7.4.3 NEW ENGLAND BIOLABS
      • 7.4.3.1 Company overview
      • 7.4.3.2 Financial performance
      • 7.4.3.3 Product benchmarking
      • 7.4.3.4 Strategic initiatives
    • 7.4.4 GENSCRIPT
      • 7.4.4.1 Company overview
      • 7.4.4.2 Financial performance
      • 7.4.4.3 Product benchmarking
      • 7.4.4.4 Strategic initiatives
    • 7.4.5 INTEGRATED DNA TECHNOLOGIES INC.
      • 7.4.5.1 Company overview
      • 7.4.5.2 Financial performance
      • 7.4.5.3 Product benchmarking
      • 7.4.5.4 Strategic initiatives
    • 7.4.6 PROMEGA CORPORATION
      • 7.4.6.1 Company overview
      • 7.4.6.2 Financial performance
      • 7.4.6.3 Product benchmarking
      • 7.4.6.4 Strategic initiatives
    • 7.4.7 APPLIED BIOLOGICAL MATERIALS INC.
      • 7.4.7.1 Company overview
      • 7.4.7.2 Financial performance
      • 7.4.7.3 Product benchmarking
      • 7.4.7.4 Strategic initiatives
    • 7.4.8 BIO-RAD LABORATORIES INC.
      • 7.4.8.1 Company overview
      • 7.4.8.2 Financial performance
      • 7.4.8.3 Product benchmarking
      • 7.4.8.4 Strategic initiatives
    • 7.4.9 BIOVISION INC.
      • 7.4.9.1 Company overview
      • 7.4.9.2 Financial performance
      • 7.4.9.3 Product benchmarking
      • 7.4.9.4 Strategic initiatives
    • 7.4.10 SYNTHEGO
      • 7.4.10.1 Company overview
      • 7.4.10.2 Financial performance
      • 7.4.10.3 Product benchmarking
      • 7.4.10.4 Strategic initiatives
    • 7.4.11 ADDGENE
      • 7.4.11.1 Company overview
      • 7.4.11.2 Financial performance
      • 7.4.11.3 Product benchmarking
      • 7.4.11.4 Strategic initiatives
    • 7.4.12 LUCIGEN
      • 7.4.12.1 Company overview
      • 7.4.12.2 Financial performance
      • 7.4.12.3 Product benchmarking
      • 7.4.12.4 Strategic initiatives

List of Tables

  • Table 1 Improvements of CRISPR/Cas9
  • Table 2 North America mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
  • Table 3 North America (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 4 North America TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 5 North America ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 6 North America Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 7 North America mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
  • Table 8 U.S. mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
  • Table 9 U.S. (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 10 U.S. TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 11 U.S. ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 12 U.S. Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 13 U.S. mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
  • Table 14 Canada mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
  • Table 15 Canada (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 16 Canada TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 17 Canada ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 18 Canada Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 19 Canada mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
  • Table 20 Europe mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
  • Table 21 Europe (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 22 Europe TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 23 Europe ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 24 Europe Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 25 Europe mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
  • Table 26 Germany mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
  • Table 27 Germany (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 28 Germany TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 29 Germany ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 30 Germany Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 31 Germany mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
  • Table 32 U.K. mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
  • Table 33 U.K. (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 34 U.K. TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 35 U.K. ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 36 U.K. Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 37 U.K. mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
  • Table 38 France mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
  • Table 39 France (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 40 France TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 41 France ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 42 France Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 43 France mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
  • Table 44 Italy mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
  • Table 45 Italy (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 46 Italy TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 47 Italy ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 48 Italy Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 49 Italy mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
  • Table 50 Spain mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
  • Table 51 Spain (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 52 Spain TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 53 Spain ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 54 Spain Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 55 Spain mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
  • Table 56 Asia Pacific mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
  • Table 57 Asia Pacific (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 58 Asia Pacific TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 59 Asia Pacific ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 60 Asia Pacific Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 61 Asia Pacific mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
  • Table 62 Japan mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
  • Table 63 Japan (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 64 Japan TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 65 Japan ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 66 Japan Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 67 Japan mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
  • Table 68 China mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
  • Table 69 China (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 70 China TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 71 China ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 72 China Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 73 China mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
  • Table 74 India mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
  • Table 75 India (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 76 India TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 77 India ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 78 India Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 79 India mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
  • Table 80 South Korea mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
  • Table 81 South Korea (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 82 South Korea TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 83 South Korea ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 84 South Korea Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 85 South Korea mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
  • Table 86 Latin America mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
  • Table 87 Latin America (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 88 Latin America TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 89 Latin America ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 90 Latin America Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 91 Latin America mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
  • Table 92 Brazil mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
  • Table 93 Brazil (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 94 Brazil TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 95 Brazil ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 96 Brazil Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 97 Brazil mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
  • Table 98 Mexico mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
  • Table 99 Mexico (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 100 Mexico TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 101 Mexico ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 102 Mexico Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 103 Mexico mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
  • Table 104 MEA mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
  • Table 105 MEA (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 106 MEA TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 107 MEA ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 108 MEA Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 109 MEA mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
  • Table 110 South Africa mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
  • Table 111 South Africa (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 112 South Africa TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 113 South Africa ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 114 South Africa Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 115 South Africa mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)
  • Table 116 Saudi Arabia mutation detection kits in genome editing market, by technology, 2017 - 2028 (USD Thousand)
  • Table 117 Saudi Arabia (CRISPR)/Cas9 mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 118 Saudi Arabia TALENs/MegaTALs mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 119 Saudi Arabia ZFN mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 120 Saudi Arabia Meganuclease mutation detection kits in genome editing market, by application, 2017 - 2028 (USD Thousand)
  • Table 121 Saudi Arabia mutation detection kits in genome editing market, by end-use, 2017 - 2028 (USD Thousand)

List of Figures

Fig. 1 Market research process

Fig. 2 Data triangulation techniques

Fig. 3 Primary research pattern

Fig. 4 Market research approaches

Fig. 5 Value-chain-based sizing & forecasting

Fig. 6 QFD modeling for market share assessment

Fig. 7 Market formulation & validation

Fig. 8 Methodology

Fig. 9 Parent market study

Fig. 10 Parent market components

Fig. 11 Penetration analysis of individual technology for global market modeling

Fig. 12 Penetration analysis of individual technology for global market modeling

Fig. 13 GMOs classification

Fig. 14 Global area of biotech crops in 2018 and 2019: by country (million hectares)

Fig. 15 Commodity flow analysis

Fig. 16 Mutation detection kits (genome editing) market snapshot, 2020 (USD Thousand)

Fig. 17 Mutation detection kits (genome editing) market segmentation

Fig. 18 Market trends & outlook

Fig. 19 Market drivers impact

Fig. 20 Market restraints impact

Fig. 21 SWOT Analysis, By Factor (Political & legal, economic, and technological)

Fig. 22 Porter's Five Forces Analysis

Fig. 23 Penetration and growth prospect mapping

Fig. 24 Mutation detection kits (genome editing) market: Technology outlook & key takeaways

Fig. 25 CRISPR market estimates and forecast by application 2017 - 2028 (USD Thousand)

Fig. 26 ZFN market estimates and forecast by application 2017 - 2028 (USD Thousand)

Fig. 27 TALENs/MegaTALs market estimates and forecast by application 2017 - 2028 (USD Thousand)

Fig. 28 Meganucleases market estimates and forecast by application 2017 - 2028 (USD Thousand)

Fig. 29 Others market estimates and forecast by application 2017 - 2028 (USD Thousand)

Fig. 30 Mutation detection kits (genome editing) market: End-use outlook and key takeaways

Fig. 31 Mutation detection kits (genome editing) market for biotechnology and pharmaceutical companies, 2017 - 2028 (USD Thousand)

Fig. 32 Mutation detection kits (genome editing) market for academic and government research institutes, 2017 - 2028 (USD Thousand)

Fig. 33 Mutation detection kits (genome editing) market for contract research organizations, 2017 - 2028 (USD Thousand)

Fig. 34 Mutation detection kits (genome editing) market: Regional outlook and key takeaways

Fig. 35 North America

Fig. 36 North America mutation detection kits (genome editing) market, 2017 - 2028 (USD Thousand)

Fig. 37 U.S.

Fig. 38 U.S. mutation detection kits (genome editing) market, 2017 - 2028 (USD Thousand)

Fig. 39 Canada

Fig. 40 Canada mutation detection kits (genome editing) market, 2017 - 2028 (USD Thousand)

Fig. 41 Europe

Fig. 42 Europe mutation detection kits (genome editing) market, 2017 - 2028 (USD Thousand)

Fig. 43 Germany

Fig. 44 Germany mutation detection kits (genome editing) market, 2017 - 2028 (USD Thousand)

Fig. 45 U.K.

Fig. 46 U.K.mutation detection kits (genome editing) market, 2017 - 2028 (USD Thousand)

Fig. 47 France

Fig. 48 France mutation detection kits (genome editing) market, 2017 - 2028 (USD Thousand)

Fig. 49 Italy

Fig. 50 Italy mutation detection kits (genome editing) market, 2017 - 2028 (USD Thousand)

Fig. 51 Spain

Fig. 52 Spain mutation detection kits (genome editing) market, 2017 - 2028 (USD Thousand)

Fig. 53 Asia Pacific

Fig. 54 Asia Pacific mutation detection kits (genome editing) market, 2017 - 2028 (USD Thousand)

Fig. 55 Japan

Fig. 56 Japan mutation detection kits (genome editing) market, 2017 - 2028 (USD Thousand)

Fig. 57 China

Fig. 58 China mutation detection kits (genome editing) market, 2017 - 2028 (USD Thousand)

Fig. 59 India

Fig. 60 India mutation detection kits (genome editing) market, 2017 - 2028 (USD Thousand)

Fig. 61 South Korea

Fig. 62 South Korea mutation detection kits (genome editing) market, 2017 - 2028 (USD Thousand)

Fig. 63 Latin America

Fig. 64 Latin America mutation detection kits (genome editing) market, 2017 - 2028 (USD Thousand)

Fig. 65 Brazil

Fig. 66 Brazil mutation detection kits (genome editing) market, 2017 - 2028 (USD Thousand)

Fig. 67 Mexico

Fig. 68 Mexico mutation detection kits (genome editing) market, 2017 - 2028 (USD Thousand)

Fig. 69 MEA

Fig. 70 MEA mutation detection kits (genome editing) market, 2017 - 2028 (USD Thousand)

Fig. 71 South Africa

Fig. 72 South Africa mutation detection kits (genome editing) market, 2017 - 2028 (USD Thousand)

Fig. 73 Saudi Arabia

Fig. 74 Saudi Arabia mutation detection kits (genome editing) market, 2017 - 2028 (USD Thousand)

Fig. 75 Company market share, 2020 (%)

Fig. 76 Strategy framework

Fig. 77 Participant categorization